aluates Reports

$ 0.0

Automative

Global Gene Therapy for CNS Disorders Market Research Report 2025

Published Date: September 2025

Report Code: QYRE-Auto-32D17091

Global Gene Therapy for CNS Disorders Market Research Report 2024

BUY CHAPTERS

Global Gene Therapy for CNS Disorders Market Research Report 2025

Code: QYRE-Auto-32D17091

Report

September 2025

Pages:70

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Gilead (Kite Pharma)

Amgen (BioVex)

Novartis

Roche (Spark Therapeutics)

Bluebird bio

Gene Therapy for CNS Disorders Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Gene Therapy for CNS Disorders Market

The global market for Gene Therapy for CNS Disorders was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

Gene Therapy is an experimental treatment that involves introducing genetic material into a person’s cells to fight or prevent disease. A gene can be delivered to a cell using a carrier known as a “vector.” The most common types of vectors used in gene therapy are viruses. The viruses used in gene therapy are altered to make them safe, although some risks still exist with gene therapy. The technology is still in its infancy.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Gene Therapy for CNS Disorders, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gene Therapy for CNS Disorders.

The Gene Therapy for CNS Disorders market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Gene Therapy for CNS Disorders market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Gene Therapy for CNS Disorders companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Gene Therapy for CNS Disorders Market Report

Report Metric	Details
Report Name	Gene Therapy for CNS Disorders Market
CAGR	5%
Segment by Type	Ex Vivo In Vivo
Segment by Application	Hospitals Clinics Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Gilead (Kite Pharma), Amgen (BioVex), Novartis, Roche (Spark Therapeutics), Bluebird Bio
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Gene Therapy for CNS Disorders company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Gene Therapy for CNS Disorders Market report?

Ans: The main players in the Gene Therapy for CNS Disorders Market are Gilead (Kite Pharma), Amgen (BioVex), Novartis, Roche (Spark Therapeutics), Bluebird Bio

What are the Application segmentation covered in the Gene Therapy for CNS Disorders Market report?

Ans: The Applications covered in the Gene Therapy for CNS Disorders Market report are Hospitals, Clinics, Others

What are the Type segmentation covered in the Gene Therapy for CNS Disorders Market report?

Ans: The Types covered in the Gene Therapy for CNS Disorders Market report are Ex Vivo, In Vivo

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Gene Therapy for CNS Disorders Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Ex Vivo

1.2.3 In Vivo

1.3 Market by Application

1.3.1 Global Gene Therapy for CNS Disorders Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospitals

1.3.3 Clinics

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Gene Therapy for CNS Disorders Market Perspective (2020-2031)

2.2 Global Gene Therapy for CNS Disorders Growth Trends by Region

2.2.1 Global Gene Therapy for CNS Disorders Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Gene Therapy for CNS Disorders Historic Market Size by Region (2020-2025)

2.2.3 Gene Therapy for CNS Disorders Forecasted Market Size by Region (2026-2031)

2.3 Gene Therapy for CNS Disorders Market Dynamics

2.3.1 Gene Therapy for CNS Disorders Industry Trends

2.3.2 Gene Therapy for CNS Disorders Market Drivers

2.3.3 Gene Therapy for CNS Disorders Market Challenges

2.3.4 Gene Therapy for CNS Disorders Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Gene Therapy for CNS Disorders Players by Revenue

3.1.1 Global Top Gene Therapy for CNS Disorders Players by Revenue (2020-2025)

3.1.2 Global Gene Therapy for CNS Disorders Revenue Market Share by Players (2020-2025)

3.2 Global Gene Therapy for CNS Disorders Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Gene Therapy for CNS Disorders Revenue

3.4 Global Gene Therapy for CNS Disorders Market Concentration Ratio

3.4.1 Global Gene Therapy for CNS Disorders Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Gene Therapy for CNS Disorders Revenue in 2024

3.5 Global Key Players of Gene Therapy for CNS Disorders Head office and Area Served

3.6 Global Key Players of Gene Therapy for CNS Disorders, Product and Application

3.7 Global Key Players of Gene Therapy for CNS Disorders, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Gene Therapy for CNS Disorders Breakdown Data by Type

4.1 Global Gene Therapy for CNS Disorders Historic Market Size by Type (2020-2025)

4.2 Global Gene Therapy for CNS Disorders Forecasted Market Size by Type (2026-2031)

5 Gene Therapy for CNS Disorders Breakdown Data by Application

5.1 Global Gene Therapy for CNS Disorders Historic Market Size by Application (2020-2025)

5.2 Global Gene Therapy for CNS Disorders Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Gene Therapy for CNS Disorders Market Size (2020-2031)

6.2 North America Gene Therapy for CNS Disorders Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Gene Therapy for CNS Disorders Market Size by Country (2020-2025)

6.4 North America Gene Therapy for CNS Disorders Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Gene Therapy for CNS Disorders Market Size (2020-2031)

7.2 Europe Gene Therapy for CNS Disorders Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Gene Therapy for CNS Disorders Market Size by Country (2020-2025)

7.4 Europe Gene Therapy for CNS Disorders Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Gene Therapy for CNS Disorders Market Size (2020-2031)

8.2 Asia-Pacific Gene Therapy for CNS Disorders Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Gene Therapy for CNS Disorders Market Size by Region (2020-2025)

8.4 Asia-Pacific Gene Therapy for CNS Disorders Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Gene Therapy for CNS Disorders Market Size (2020-2031)

9.2 Latin America Gene Therapy for CNS Disorders Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Gene Therapy for CNS Disorders Market Size by Country (2020-2025)

9.4 Latin America Gene Therapy for CNS Disorders Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Gene Therapy for CNS Disorders Market Size (2020-2031)

10.2 Middle East & Africa Gene Therapy for CNS Disorders Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Gene Therapy for CNS Disorders Market Size by Country (2020-2025)

10.4 Middle East & Africa Gene Therapy for CNS Disorders Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Gilead (Kite Pharma)

11.1.1 Gilead (Kite Pharma) Company Details

11.1.2 Gilead (Kite Pharma) Business Overview

11.1.3 Gilead (Kite Pharma) Gene Therapy for CNS Disorders Introduction

11.1.4 Gilead (Kite Pharma) Revenue in Gene Therapy for CNS Disorders Business (2020-2025)

11.1.5 Gilead (Kite Pharma) Recent Development

11.2 Amgen (BioVex)

11.2.1 Amgen (BioVex) Company Details

11.2.2 Amgen (BioVex) Business Overview

11.2.3 Amgen (BioVex) Gene Therapy for CNS Disorders Introduction

11.2.4 Amgen (BioVex) Revenue in Gene Therapy for CNS Disorders Business (2020-2025)

11.2.5 Amgen (BioVex) Recent Development

11.3 Novartis

11.3.1 Novartis Company Details

11.3.2 Novartis Business Overview

11.3.3 Novartis Gene Therapy for CNS Disorders Introduction

11.3.4 Novartis Revenue in Gene Therapy for CNS Disorders Business (2020-2025)

11.3.5 Novartis Recent Development

11.4 Roche (Spark Therapeutics)

11.4.1 Roche (Spark Therapeutics) Company Details

11.4.2 Roche (Spark Therapeutics) Business Overview

11.4.3 Roche (Spark Therapeutics) Gene Therapy for CNS Disorders Introduction

11.4.4 Roche (Spark Therapeutics) Revenue in Gene Therapy for CNS Disorders Business (2020-2025)

11.4.5 Roche (Spark Therapeutics) Recent Development

11.5 Bluebird Bio

11.5.1 Bluebird Bio Company Details

11.5.2 Bluebird Bio Business Overview

11.5.3 Bluebird Bio Gene Therapy for CNS Disorders Introduction

11.5.4 Bluebird Bio Revenue in Gene Therapy for CNS Disorders Business (2020-2025)

11.5.5 Bluebird Bio Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Gilead (Kite Pharma)

Amgen (BioVex)

Novartis

Roche (Spark Therapeutics)

Bluebird bio

List of Tables

Table 1. Global Gene Therapy for CNS Disorders Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Ex Vivo

Table 3. Key Players of In Vivo

Table 4. Global Gene Therapy for CNS Disorders Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 5. Global Gene Therapy for CNS Disorders Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Gene Therapy for CNS Disorders Market Size by Region (2020-2025) & (US$ Million)

Table 7. Global Gene Therapy for CNS Disorders Market Share by Region (2020-2025)

Table 8. Global Gene Therapy for CNS Disorders Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 9. Global Gene Therapy for CNS Disorders Market Share by Region (2026-2031)

Table 10. Gene Therapy for CNS Disorders Market Trends

Table 11. Gene Therapy for CNS Disorders Market Drivers

Table 12. Gene Therapy for CNS Disorders Market Challenges

Table 13. Gene Therapy for CNS Disorders Market Restraints

Table 14. Global Gene Therapy for CNS Disorders Revenue by Players (2020-2025) & (US$ Million)

Table 15. Global Gene Therapy for CNS Disorders Market Share by Players (2020-2025)

Table 16. Global Top Gene Therapy for CNS Disorders Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Therapy for CNS Disorders as of 2024)

Table 17. Ranking of Global Top Gene Therapy for CNS Disorders Companies by Revenue (US$ Million) in 2024

Table 18. Global 5 Largest Players Market Share by Gene Therapy for CNS Disorders Revenue (CR5 and HHI) & (2020-2025)

Table 19. Global Key Players of Gene Therapy for CNS Disorders, Headquarters and Area Served

Table 20. Global Key Players of Gene Therapy for CNS Disorders, Product and Application

Table 21. Global Key Players of Gene Therapy for CNS Disorders, Date of Enter into This Industry

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Gene Therapy for CNS Disorders Market Size by Type (2020-2025) & (US$ Million)

Table 24. Global Gene Therapy for CNS Disorders Revenue Market Share by Type (2020-2025)

Table 25. Global Gene Therapy for CNS Disorders Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 26. Global Gene Therapy for CNS Disorders Revenue Market Share by Type (2026-2031)

Table 27. Global Gene Therapy for CNS Disorders Market Size by Application (2020-2025) & (US$ Million)

Table 28. Global Gene Therapy for CNS Disorders Revenue Market Share by Application (2020-2025)

Table 29. Global Gene Therapy for CNS Disorders Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 30. Global Gene Therapy for CNS Disorders Revenue Market Share by Application (2026-2031)

Table 31. North America Gene Therapy for CNS Disorders Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 32. North America Gene Therapy for CNS Disorders Market Size by Country (2020-2025) & (US$ Million)

Table 33. North America Gene Therapy for CNS Disorders Market Size by Country (2026-2031) & (US$ Million)

Table 34. Europe Gene Therapy for CNS Disorders Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. Europe Gene Therapy for CNS Disorders Market Size by Country (2020-2025) & (US$ Million)

Table 36. Europe Gene Therapy for CNS Disorders Market Size by Country (2026-2031) & (US$ Million)

Table 37. Asia-Pacific Gene Therapy for CNS Disorders Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 38. Asia-Pacific Gene Therapy for CNS Disorders Market Size by Region (2020-2025) & (US$ Million)

Table 39. Asia-Pacific Gene Therapy for CNS Disorders Market Size by Region (2026-2031) & (US$ Million)

Table 40. Latin America Gene Therapy for CNS Disorders Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 41. Latin America Gene Therapy for CNS Disorders Market Size by Country (2020-2025) & (US$ Million)

Table 42. Latin America Gene Therapy for CNS Disorders Market Size by Country (2026-2031) & (US$ Million)

Table 43. Middle East & Africa Gene Therapy for CNS Disorders Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Middle East & Africa Gene Therapy for CNS Disorders Market Size by Country (2020-2025) & (US$ Million)

Table 45. Middle East & Africa Gene Therapy for CNS Disorders Market Size by Country (2026-2031) & (US$ Million)

Table 46. Gilead (Kite Pharma) Company Details

Table 47. Gilead (Kite Pharma) Business Overview

Table 48. Gilead (Kite Pharma) Gene Therapy for CNS Disorders Product

Table 49. Gilead (Kite Pharma) Revenue in Gene Therapy for CNS Disorders Business (2020-2025) & (US$ Million)

Table 50. Gilead (Kite Pharma) Recent Development

Table 51. Amgen (BioVex) Company Details

Table 52. Amgen (BioVex) Business Overview

Table 53. Amgen (BioVex) Gene Therapy for CNS Disorders Product

Table 54. Amgen (BioVex) Revenue in Gene Therapy for CNS Disorders Business (2020-2025) & (US$ Million)

Table 55. Amgen (BioVex) Recent Development

Table 56. Novartis Company Details

Table 57. Novartis Business Overview

Table 58. Novartis Gene Therapy for CNS Disorders Product

Table 59. Novartis Revenue in Gene Therapy for CNS Disorders Business (2020-2025) & (US$ Million)

Table 60. Novartis Recent Development

Table 61. Roche (Spark Therapeutics) Company Details

Table 62. Roche (Spark Therapeutics) Business Overview

Table 63. Roche (Spark Therapeutics) Gene Therapy for CNS Disorders Product

Table 64. Roche (Spark Therapeutics) Revenue in Gene Therapy for CNS Disorders Business (2020-2025) & (US$ Million)

Table 65. Roche (Spark Therapeutics) Recent Development

Table 66. Bluebird Bio Company Details

Table 67. Bluebird Bio Business Overview

Table 68. Bluebird Bio Gene Therapy for CNS Disorders Product

Table 69. Bluebird Bio Revenue in Gene Therapy for CNS Disorders Business (2020-2025) & (US$ Million)

Table 70. Bluebird Bio Recent Development

Table 71. Research Programs/Design for This Report

Table 72. Key Data Information from Secondary Sources

Table 73. Key Data Information from Primary Sources

Table 74. Authors List of This Report

List of Figures

Figure 1. Gene Therapy for CNS Disorders Picture

Figure 2. Global Gene Therapy for CNS Disorders Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Gene Therapy for CNS Disorders Market Share by Type: 2024 VS 2031

Figure 4. Ex Vivo Features

Figure 5. In Vivo Features

Figure 6. Global Gene Therapy for CNS Disorders Market Size by Application (2020-2031) & (US$ Million)

Figure 7. Global Gene Therapy for CNS Disorders Market Share by Application: 2024 VS 2031

Figure 8. Hospitals Case Studies

Figure 9. Clinics Case Studies

Figure 10. Others Case Studies

Figure 11. Gene Therapy for CNS Disorders Report Years Considered

Figure 12. Global Gene Therapy for CNS Disorders Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 13. Global Gene Therapy for CNS Disorders Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 14. Global Gene Therapy for CNS Disorders Market Share by Region: 2024 VS 2031

Figure 15. Global Gene Therapy for CNS Disorders Market Share by Players in 2024

Figure 16. Global Top Gene Therapy for CNS Disorders Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Therapy for CNS Disorders as of 2024)

Figure 17. The Top 10 and 5 Players Market Share by Gene Therapy for CNS Disorders Revenue in 2024

Figure 18. North America Gene Therapy for CNS Disorders Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 19. North America Gene Therapy for CNS Disorders Market Share by Country (2020-2031)

Figure 20. United States Gene Therapy for CNS Disorders Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. Canada Gene Therapy for CNS Disorders Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Europe Gene Therapy for CNS Disorders Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe Gene Therapy for CNS Disorders Market Share by Country (2020-2031)

Figure 24. Germany Gene Therapy for CNS Disorders Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. France Gene Therapy for CNS Disorders Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. U.K. Gene Therapy for CNS Disorders Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Italy Gene Therapy for CNS Disorders Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Russia Gene Therapy for CNS Disorders Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Nordic Countries Gene Therapy for CNS Disorders Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Asia-Pacific Gene Therapy for CNS Disorders Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific Gene Therapy for CNS Disorders Market Share by Region (2020-2031)

Figure 32. China Gene Therapy for CNS Disorders Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Japan Gene Therapy for CNS Disorders Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. South Korea Gene Therapy for CNS Disorders Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Southeast Asia Gene Therapy for CNS Disorders Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. India Gene Therapy for CNS Disorders Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Australia Gene Therapy for CNS Disorders Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Latin America Gene Therapy for CNS Disorders Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America Gene Therapy for CNS Disorders Market Share by Country (2020-2031)

Figure 40. Mexico Gene Therapy for CNS Disorders Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Brazil Gene Therapy for CNS Disorders Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Middle East & Africa Gene Therapy for CNS Disorders Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa Gene Therapy for CNS Disorders Market Share by Country (2020-2031)

Figure 44. Turkey Gene Therapy for CNS Disorders Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Saudi Arabia Gene Therapy for CNS Disorders Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. UAE Gene Therapy for CNS Disorders Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Gilead (Kite Pharma) Revenue Growth Rate in Gene Therapy for CNS Disorders Business (2020-2025)

Figure 48. Amgen (BioVex) Revenue Growth Rate in Gene Therapy for CNS Disorders Business (2020-2025)

Figure 49. Novartis Revenue Growth Rate in Gene Therapy for CNS Disorders Business (2020-2025)

Figure 50. Roche (Spark Therapeutics) Revenue Growth Rate in Gene Therapy for CNS Disorders Business (2020-2025)

Figure 51. Bluebird Bio Revenue Growth Rate in Gene Therapy for CNS Disorders Business (2020-2025)

Figure 52. Bottom-up and Top-down Approaches for This Report

Figure 53. Data Triangulation

Figure 54. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Gene Therapy Sales Market Report Competitive Analysis and Regional Opportunities 2025 2031

Gene Therapy on Neurological Diseases Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Gene Therapy for Inherited Genetic Disorders Market Insights Forecast to 2030

Global Human Gene Therapy Market Research Report 2025

Gene Therapy based Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Gene Therapy For Cancer Market Research Report 2024

Global Gene Delivery or Gene Therapy Drug Market Research Report 2025

Gene Therapy in Cardiovascular Disorder Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Gene based Therapy Medicinal Market Research Report 2024

Global Non viral Vectors Gene Therapy Market Research Report 2025

Global Gene Therapy On Cardiovascular Disease Market Research Report 2025

Global Gene Therapy in Oncology Market Research Report 2024

Global Cell and Gene Therapy Market Research Report 2024

Global Gene Therapies for Cancer Treatment Market Research Report 2024

Viral Gene Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Gene based Advanced Therapy Medicinal Market Research Report 2025

Gene Delivery System Technology Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Gene Therapy Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Gene Delivery System Market Size Manufacturers Supply Chain Sales Channel and Clients 2024 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions